Detection of glucose abnormalities in patients with acute coronary heart disease: Study of reliable tools in clinical practice

Journal of Endocrinological Investigation

Volumn 35, Issue 1, 2012, Pages 71-76

  Del Olmo, M I ^a   Merino Torres, J F ^a   Argente, M ^a   Ramos, A ^a   Navas, M S ^a   Campos, V ^a   Camara R ^a   Perez Lazaro A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute coronary syndrome; Glucose abnormalities; Oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL PRACTICE; CORONARY CARE UNIT; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT CODING; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84861993077     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7769     Document Type: Article

References (25)

1. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22: 23340.
2. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999, 354: 617-21.
3. Bjornholt JV, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999, 22: 45-9. (Pubitemid 29028297)
4. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359: 2140-4. (Pubitemid 34694020)
5. Bartnik M, Rydén L, Ferrari R, et al Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004, 25: 1880-90. (Pubitemid 39452604)
6. Hu DY, Pan CY, Yu JM; China Heart Survey Group. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006, 27: 2573-9.
7. Lenzen M, Ryden L, Ohrvik J, et al Euro Heart Survey Investigators. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1 -year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006, 27: 2969-74.
8. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Rydén L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004, 25: 1990-7. (Pubitemid 39486017)
9. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglicemia in the diagnosis and prediction of diabetes. Diabetes Care 2000, 23: 1108-12. (Pubitemid 30616797)
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15: 539-53. (Pubitemid 28319935)
11. Wallander M, Malmberg K, Nomammar A, Rydén L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008, 31: 36-8.
12. Bartnik M, Rydén L, Malmberg K, et al Euro Heart Survey Investigators. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007, 93: 72-7. (Pubitemid 46094058)
13. Egstrup M, Henriksen FL, Høfsten DE, Jensen BK, Hangaard J, Egstrup K. Prevalence of glucometabolic abnormalities in connection with myocardial infarction in a Danish coronary care unit. Ugeskr Laeger 2008, 170: 942-6.
14. Rydén L, Standl E, Bartnik M, et al; Grupo de Trabajo sobre Diabetes y Enfermedades Cardiovasculares de la Sociedad Europea de Cardiología y de la Sociedad Europea para el Estudio de la Diabetes. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Rev Esp Cardiol 2007, 60: 1e-64e.
15. Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009, 41: 86-97.
16. Choi KM, Lee KW, Kim SG, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005, 90: 175-80. (Pubitemid 40116653)
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9. (Pubitemid 15018832)
18. Qiao Q, Pyörälä K, Pyörälä M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002, 23: 1267-75. (Pubitemid 35238508)
19. Gołembiewska E. Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities. Ann Acad Med Stetin 2004, 50: 131-8.
20. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362: 800-11.
21. Vrolix R, van Meijl LE, Mensink RP. The metabolic syndrome in relation with the glycemic index and the glycemic load. Physiol Behav 2008, 94: 293-9. (Pubitemid 351615423)
22. Keller U. From obesity to diabetes. Int J Vitam Nutr Res 2006, 76: 172-7. (Pubitemid 46173282)
23. García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R; AVANT Study Group Investigators. Glucose metabolism in patients with essential hypertension. Am J Med 2006, 119: 318-26.
24. Chen YX, Wang XQ, Wang JF, et al. Glucometabolic state of inhospital patients with primary hypertension in sub-population of partial regions in China. J Hum Hypertens 2008, 22: 346-51.
25. Taubert G, Winkelmann BR, Schleiffer T, et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003, 145: 285-91. (Pubitemid 36207950)